Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy

about

Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology.

P2860

Q37578603-1900F4AF-7327-41B6-93ED-AB12833F7FA0

P2860

Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy

Item

http://www.wikidata.org/entity/Q57173424

description

scientific article published on 04 November 2014

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2015

@uk

name

Sequential release of drugs fr ...... iers for breast cancer therapy

@en

Sequential release of drugs fr ...... iers for breast cancer therapy

@nl

type

Item

label

Sequential release of drugs fr ...... iers for breast cancer therapy

@en

Sequential release of drugs fr ...... iers for breast cancer therapy

@nl

prefLabel

Sequential release of drugs fr ...... iers for breast cancer therapy

@en

Sequential release of drugs fr ...... iers for breast cancer therapy

@nl

P1476

Sequential release of drugs fr ...... iers for breast cancer therapy

@en

P2093

Abhijit Mazumdar

http://www.w3.org/2001/XMLSchema#string

Amita Pathak

http://www.w3.org/2001/XMLSchema#string

B N Prashanth Kumar

http://www.w3.org/2001/XMLSchema#string

Devanand Sarkar

http://www.w3.org/2001/XMLSchema#string

Goutam Dey

http://www.w3.org/2001/XMLSchema#string

Ipsita Pal

http://www.w3.org/2001/XMLSchema#string

Keith R Brunt

http://www.w3.org/2001/XMLSchema#string

Luni Emdad

http://www.w3.org/2001/XMLSchema#string

Mahitosh Mandal

http://www.w3.org/2001/XMLSchema#string

Nagaprasad Puvvada

http://www.w3.org/2001/XMLSchema#string

P2860

Biological effects and safety in magnetic resonance imaging: a review

Hallmarks of Cancer: The Next Generation

Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance

Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy.

Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.

Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release.

Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte.

Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells

ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.

P304

90-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C4TB01098A

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

32261929

http://www.w3.org/2001/XMLSchema#string

P921

nanocarrier

Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy

about

P2860

P2860

Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921